title: Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects.
abstract: This study was designed to clarify the association between inter-episode bipolar disorder (BD) and sleep architecture. Participants completed a baseline symptom and sleep assessment and, 3 months later, an assessment of symptoms and impairment. The effects of psychiatric medications on sleep architecture were also considered. Participants included 22 adults with BD I or II (inter-episode) and 22 non-psychiatric controls. The sleep assessment was conducted at the Sleep and Psychological Disorders Laboratory at the University of California, Berkeley. Follow-up assessments 3 months later were conducted over the phone. Results indicate that, at the sleep assessment, BD participants exhibited greater rapid eye movement sleep (REM) density than control participants with no other group differences in sleep architecture. Sleep architecture was not correlated with concurrent mood symptoms in either group. In the BD group, duration of the first REM period and slow-wave sleep (SWS) amount were positively correlated with manic symptoms and impairment at 3 months, while REM density was positively correlated with depressive symptoms and impairment at 3 months. The amount of Stage 2 sleep was negatively correlated with manic symptoms and impairment at 3 months. In contrast, for the control group, REM density was negatively correlated with impairment at 3 months. SWS and Stage 2 sleep were not correlated with symptoms or impairment. Study findings suggest that inter-episode REM sleep, SWS and Stage 2 sleep are correlated with future manic and depressive symptoms and impairment in BD. This is consistent with the proposition that sleep architecture may be a mechanism of illness maintenance in BD.
authors.affiliation: Department of Psychology, University of California, Berkeley, CA 94720-1650, USA.
authors.forename: Polina
authors.initials: P
authors.lastname: Eidelman
authors.forename: Lisa S
authors.initials: LS
authors.lastname: Talbot
authors.forename: June
authors.initials: J
authors.lastname: Gruber
authors.forename: Ilana
authors.initials: I
authors.lastname: Hairston
authors.forename: Allison G
authors.initials: AG
authors.lastname: Harvey
mesh_terms: D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017286:Polysomnography; D012890:Sleep / Q000187:drug effects / Q000502:physiology; D012893:Sleep Wake Disorders / Q000150:complications* / Q000209:etiology / Q000503:physiopathology; D012895:Sleep, REM / Q000187:drug effects / Q000502:physiology; D055815:Young Adult
chemical_list: D018692:Antimanic Agents
references.citation: Br J Psychiatry. 2002 May;180:461-4
references.pmid: 11983645
references.citation: Am J Psychiatry. 1982 May;139(5):571-6
references.pmid: 7072840
references.citation: Biol Psychiatry. 1986 May;21(5-6):465-72
references.pmid: 3697436
references.citation: Sleep. 1993 Feb;16(2):100-13
references.pmid: 8446828
references.citation: Eur Neuropsychopharmacol. 2007 Jul;17(8):527-31
references.pmid: 17337164
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):22-9
references.pmid: 16048734
references.citation: Psychiatr Serv. 2006 May;57(5):660-5
references.pmid: 16675760
references.citation: Pharmacol Biochem Behav. 2007 Mar;86(3):468-76
references.pmid: 17303232
references.citation: J Exp Psychol Gen. 1994 Jun;123(2):201-15
references.pmid: 8014613
references.citation: Arch Gen Psychiatry. 2002 Jun;59(6):530-7
references.pmid: 12044195
references.citation: Psychiatry Res. 1987 Jun;21(2):89-94
references.pmid: 3615694
references.citation: Int J Neuropsychopharmacol. 2004 Sep;7(3):275-81
references.pmid: 15122973
references.citation: J Affect Disord. 2003 Apr;74(2):173-84
references.pmid: 12706519
references.citation: Hum Neurobiol. 1982;1(3):195-204
references.pmid: 7185792
references.citation: J Affect Disord. 2002 Aug;70(3):273-80
references.pmid: 12128239
references.citation: Psychiatry Res. 1998 Sep 21;80(3):249-55
references.pmid: 9796940
references.citation: Psychol Med. 1996 May;26(3):477-86
references.pmid: 8733206
references.citation: Psychopharmacology (Berl). 2007 Mar;190(4):507-16
references.pmid: 17205319
references.citation: Psychopharmacology (Berl). 2001 Mar 1;154(2):189-97
references.pmid: 11314681
references.citation: Sleep Med. 2003 Jan;4(1):51-5
references.pmid: 14592360
references.citation: Am J Psychiatry. 2008 Jul;165(7):820-9
references.pmid: 18519522
references.citation: Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):61-8
references.pmid: 15146334
references.citation: Biol Psychiatry. 1986 Nov;21(13):1340-3
references.pmid: 3756280
references.citation: J Clin Psychopharmacol. 1994 Feb;14(1):36-40
references.pmid: 7512100
references.citation: Sleep. 1987 Oct;10(5):443-51
references.pmid: 3685752
references.citation: J Affect Disord. 2003 May;74(3):209-17
references.pmid: 12738039
references.citation: Arch Gen Psychiatry. 2005 Jun;62(6):617-27
references.pmid: 15939839
references.citation: Psychopharmacology (Berl). 1989;98(1):139-40
references.pmid: 2498958
references.citation: Psychopharmacology (Berl). 2004 Jul;174(3):421-9
references.pmid: 15029469
references.citation: Sleep. 2000 Feb 1;23(1):87-95
references.pmid: 10678469
references.citation: Br J Psychiatry. 1978 Nov;133:429-35
references.pmid: 728692
references.citation: Arch Gen Psychiatry. 1992 Aug;49(8):651-68; discussion 669-70
references.pmid: 1386215
references.citation: Epilepsy Behav. 2000 Dec;1(6):378-383
references.pmid: 12737827
references.citation: Biol Psychiatry. 1998 Jul 1;44(1):3-14
references.pmid: 9646878
references.citation: Behav Brain Res. 2008 Mar 5;187(2):254-61
references.pmid: 17964671
references.citation: Neuropsychobiology. 2005;51(4):214-25
references.pmid: 15915004
references.citation: Sleep Med Rev. 2003 Oct;7(5):423-40
references.pmid: 14573378
references.citation: Biol Psychiatry. 2005 Nov 1;58(9):694-9
references.pmid: 16018976
references.citation: Arch Gen Psychiatry. 1992 May;49(5):378-83
references.pmid: 1586273
references.citation: Psychopharmacology (Berl). 1994 Dec;116(4):389-95
references.pmid: 7701038
references.citation: Am J Psychiatry. 1998 Feb;155(2):192-9
references.pmid: 9464197
references.citation: Sleep. 2006 Mar;29(3):307-16
references.pmid: 16553016
references.citation: Psychopharmacol Bull. 1996;32(4):637-46
references.pmid: 8993085
references.citation: J Psychiatr Res. 2000 Nov-Dec;34(6):423-38
references.pmid: 11165310
references.citation: Am J Psychiatry. 2008 Mar;165(3):313-20
references.pmid: 18245175
references.citation: Am J Physiol. 1996 Sep;271(3 Pt 2):R501-10
references.pmid: 8853369
references.citation: Pharmacopsychiatry. 1987 Jan;20(1):23-9
references.pmid: 3823126
references.citation: Sleep. 2003 May 1;26(3):313-7
references.pmid: 12749551
references.citation: Sleep. 2005 Jul;28(7):829-36
references.pmid: 16124661
references.citation: Bipolar Disord. 2006 Jun;8(3):271-4
references.pmid: 16696829
references.citation: Arch Gen Psychiatry. 1988 Mar;45(3):267-73
references.pmid: 3341881
references.citation: Neuropsychopharmacology. 2002 Apr;26(4):530-6
references.pmid: 11927177
references.citation: Int J Clin Pharmacol Res. 1989;9(3):183-95
references.pmid: 2568348
references.citation: Can J Psychiatry. 1986 May;31(4):295-8
references.pmid: 3708522
references.citation: Am J Psychiatry. 1987 Feb;144(2):201-4
references.pmid: 3812788
references.citation: Biol Psychiatry. 1997 Aug 15;42(4):260-6
references.pmid: 9270902
references.citation: J Clin Psychopharmacol. 2003 Dec;23(6):540-8
references.pmid: 14624183
references.citation: Curr Biol. 2007 Oct 23;17(20):R877-8
references.pmid: 17956744
references.citation: Sleep. 2004 Dec 15;27(8):1567-96
references.pmid: 15683149